Beta blockers and cardiac resynchronization show greatest survival benefit for patients with heart failure

Data on the comparative merits of drugs recommended to manage heart failure (HF) are limited. A recent case-control study compared HF patients who died within 24 months of diagnosis with those who survived to 24 months after a HF diagnosis. The researchers compared the 2 groups to see which therapies conferred the greatest survival benefit.

“Public awareness of the necessity of lifelong medication, appropriate combination therapy, and decreased cost of devices would help Indian patients achieve better survival.”
-Azizul Haque, MD, consultant cardiologist and electrophysiologist at the BM Birla Heart Research Centre in Kolkata, India

The investigators performed medical records reviews of 1,376 patients who had died and 2,752 who remained alive at 24 months. They found that beta blockers and cardiac resynchronization therapy were...

Log in or register for free to continue reading
Register Now For Free Already Registered? Log In
This entry was posted in Cardiovascular, Non-Communicable Disease, Primary Care and tagged , , , , , , , , , , , , . Volume: .

Post a Comment

You must be logged in to post a comment.